Wednesday June 21, 2023

Name: Healthcare Business International 2023
Start: 2023-06-19
End: 2023-06-21
Location: QEII Centre, London

11:30 amSector Analysis

Laboratory diagnostics – where after Covid?

Diagnostic labs saw massive growth during Covid. How has this changed the long-term outlook for the sector? For instance, has Covid enabled the sector to successfully build new relationships with government and public payors? This session also explores growth opportunities in outsourcing, new tech, verticalisation and emerging markets

Speakers include:

Jerome Thill, Deputy CEO, Cerba

Wolf Kupatt, CEO, Amedes

Staffan Ternstrom, COO Diagnostic Services, Medicover

Jerome ThillDeputy CEOCerba Healthcare

Wolf KupattCEOAmedes

Staffan TernströmChief Operating Officer, Diagnostics ServicesMedicover

Explore similar sessions

2:30 pmSector Analysis

The evolution in Primary Care

The huge primary care sector in Europe holds the key to outpatient consolidation. Here we look at how operators are pairing it with digital and telehealth, pharmacies and imaging, and...

Dr Murray EllenderCEO and Co FoundereConsult Health Ltd

Juliet BauerChief Growth & Marketing OfficerKry

Dirk KnueppelCEOPrimärmedizin TMVZ GmbH

Martin LindmanCEO Doktor SE

2:30 pmSector Analysis

Opportunities in Oncology

There is still a long way to go to build capacity in oncology care, but with huge investor interest, linked to the close synergies with imaging diagnostics, the opportunities are...

Dr Ralf KurekExecutive PartnerRadioOnkologieNetzwerk, Ergéa Group

1:30 pmSector Analysis

Opportunities in Ophthalmology

Ophthalmology continues to be a big area of investor interest with considerable scope for consolidation. Governments are increasingly outsourcing cataract operations and the sector is starting to unlock the potential...